Merck (MRK) Share-based Compensation (2016 - 2025)
Historic Share-based Compensation for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $204.0 million.
- Merck's Share-based Compensation rose 461.54% to $204.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $802.0 million, marking a year-over-year increase of 823.21%. This contributed to the annual value of $761.0 million for FY2024, which is 1798.45% up from last year.
- Merck's Share-based Compensation amounted to $204.0 million in Q3 2025, which was up 461.54% from $216.0 million recorded in Q2 2025.
- In the past 5 years, Merck's Share-based Compensation registered a high of $216.0 million during Q2 2025, and its lowest value of $111.0 million during Q1 2021.
- Over the past 5 years, Merck's median Share-based Compensation value was $164.0 million (recorded in 2023), while the average stood at $160.1 million.
- In the last 5 years, Merck's Share-based Compensation plummeted by 714.29% in 2021 and then surged by 2335.77% in 2023.
- Over the past 5 years, Merck's Share-based Compensation (Quarter) stood at $119.0 million in 2021, then increased by 21.85% to $145.0 million in 2022, then rose by 15.17% to $167.0 million in 2023, then rose by 11.98% to $187.0 million in 2024, then rose by 9.09% to $204.0 million in 2025.
- Its last three reported values are $204.0 million in Q3 2025, $216.0 million for Q2 2025, and $195.0 million during Q1 2025.